• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    2.03 Up 0.03(1.50%) May 29, 4:00PM EDT
    |After Hours : 2.00 Down 0.03 (1.48%) May 29, 5:11PM EDT
    Add to Portfolio
    Prev Close:2.00
    Open:1.97
    Bid:1.98 x 300
    Ask:2.04 x 300
    1y Target Est:2.00
    Beta:1.01
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:1.88 - 2.12
    52wk Range:0.61 - 3.50
    Volume:2,529,917
    Avg Vol (3m):3,470,350
    Market Cap:111.79M
    P/E (ttm):N/A
    EPS (ttm):-1.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AVEOUp 1.50%111.79M
    AMGNDown 0.69%118.81B
    PFEUp 0.90%213.98B
    RHHBYUp 2.83%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):37.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.87
    Quarterly EPS Est (Jun-15) :-0.21
    Mean Recommendation*:3.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. Its product candidates under development include Tivozanib, an tyrosine kinase inhibitor for various vascular endot... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback